Article
Public (all visitors)
U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns
CNBC
2020
Resources from CNBC
The ACTIV-3 trial is one of several ongoing trials that are part of an NIH program to accelerate the development of vaccine treatments.
Comments
Keep exploring
Related resources
More to explore from shared collections and topics.
Contribute to BackpackerU Resources
Found something worth adding?
Sign in to suggest resources and start organizing your own travel-learning library.
No comments yet.